Rectal immunization of mice with hepatitis A vaccine induces stronger systemic and local immune responses than parenteral immunization

Vaccine

Volumn 21, Issue 13-14, 2003, Pages 1527-1538

  Mitchell, Leslie Ann ^a   Galun, Eithan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Hepatitis A virus (HAV); IgA; Mucosal vaccination; T cell response

Indexed keywords

ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELL ASSAY; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS A; HEPATITIS A VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTESTINE CELL; INTESTINE MUCOSA; LAMINA PROPRIA; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SPLEEN CELL;

ADMINISTRATION, RECTAL; ANIMALS; ANTIBODIES, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS A VACCINES; HEPATITIS A VIRUS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; VACCINES, ATTENUATED;

EID: 0037471401     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00699-0     Document Type: Article

References (19)

1. Koff R.S. Hepatitis A. Lancet. 351:1998;1643-1649.
2. Evans AS, editor. Viral infections in humans. Epidemiology and control. 3rd ed. NY: Plenum Medical Book Company; 1998.
3. Karayiannis P., Jowett T., Enticott M., Moore D.et al. Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver damage. J. Med. Virol. 18(3):1986;261-276.
4. Kurane I., Binn L.N., Bancroft W.H., Ennis F.A. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J. Immunol. 135(3):1985;2140-2144.
5. Gauss-Müller V., Zhou M.Q., von der Helm K., Deinhardt F. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing antibody response. J. Med. Virol. 31(4):1990;277-283.
6. Wang C.D., Tschen S.Y., Heinricy U., Weber M., Flehmig B. Immune response to hepatitis A virus capsid proteins after infection. J. Clin. Microbiol. 34(3):1996;707-713.
7. Wiedermann G., Kundi M., Abrosch F. Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule). Acta Trop. 69:1998;121-125.
8. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). CDC, MMWR 1999;48(RR1-12):1-37.
9. Iijima H., Takahashi I., Kiyono H. Mucosal immune network in the gut for the control of infectious diseases. Rev. Med. Virol. 11:2001;117-133.
10. Naksase H., Okazaki K., Tabata Y.et al. Rectal immunization with antigen-containing microspheres induces stronger TH2 response than oral immunization: a new method for vaccination. Vaccine. 20:2002;377-384.
11. Belyakov I.M., Hel Z., Kelsall B.et al. Mucosal AIDS vaccine reduced disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7:2001;1320-1326.
12. Mestecky J., Fultz P.N. Mucosal immune system of the human genital tract. J. Infect. Dis. 179:1999;5470-5474.
13. Lehner T., Wang Y., Ping L.et al. The effect of route of immunization on mucosal immunity and protection. 179:1999;S489-S492.
14. DeVos T., Dick T.A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Meth. 141:1991;285-288.
15. Jackson R.J., Fujihashi I., Xu-Amano H., Kiyono H., Elson C.O., McGhee J.R. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immunol. 61(10):1993;4272-4279.
16. Guerro R.A., Ball J.M., Krater S.S., Pacheco S.E., Clements J.D., Estes M.K. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J. Virol. 75(20):2001;9713-9722.
17. Nemchinov L.G., Liang T.J., Rifaat M.M., Mazyad H.M., Hadidi A., Keith J.M. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch. Virol. 145:2000;2557-2573.
18. Kelsall B, Stober W. Gut-associated lymphoid tissue: antigen handling and T-lymphocyte responses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal immunity. 2nd ed. San Diego (London): Academic Press; 1999. p. 293-317.
19. James SP, Kiyono H. Gastrointestinal lamina propria T cells. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity. 2nd ed. San Diego (London): Academic Press; 1999. p. 381-96.